Teladoc Health (NYSE:TDOC) Lowered to Hold at Berenberg Bank

Berenberg Bank cut shares of Teladoc Health (NYSE:TDOCGet Rating) from a buy rating to a hold rating in a research report released on Tuesday morning, Marketbeat.com reports. They currently have $35.00 target price on the health services provider’s stock.

TDOC has been the topic of several other reports. JPMorgan Chase & Co. cut Teladoc Health from an overweight rating to a neutral rating in a research report on Thursday, April 28th. Guggenheim cut Teladoc Health from a buy rating to a neutral rating in a research report on Thursday, April 28th. Needham & Company LLC cut Teladoc Health from a buy rating to a hold rating in a research report on Thursday, July 28th. Robert W. Baird dropped their price target on Teladoc Health from $72.00 to $64.00 in a research report on Wednesday, April 27th. Finally, Royal Bank of Canada dropped their price target on Teladoc Health from $215.00 to $120.00 and set an outperform rating on the stock in a research report on Tuesday, April 12th. One research analyst has rated the stock with a sell rating, twenty-two have given a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of Hold and a consensus price target of $76.10.

Teladoc Health Stock Up 0.3 %

Shares of NYSE:TDOC opened at $36.92 on Tuesday. Teladoc Health has a 1 year low of $27.38 and a 1 year high of $156.82. The company has a market cap of $5.95 billion, a PE ratio of -0.60 and a beta of 0.82. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.94 and a quick ratio of 3.71. The stock’s 50-day moving average is $36.22 and its 200 day moving average is $52.53.

Insider Transactions at Teladoc Health

In other news, CFO Mala Murthy sold 4,053 shares of the company’s stock in a transaction on Monday, June 27th. The stock was sold at an average price of $37.32, for a total value of $151,257.96. Following the completion of the sale, the chief financial officer now directly owns 27,295 shares in the company, valued at approximately $1,018,649.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, SVP Daniel Trencher sold 1,000 shares of the company’s stock in a transaction on Friday, June 17th. The shares were sold at an average price of $29.12, for a total value of $29,120.00. Following the completion of the transaction, the senior vice president now owns 28,408 shares of the company’s stock, valued at approximately $827,240.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Mala Murthy sold 4,053 shares of the company’s stock in a transaction on Monday, June 27th. The stock was sold at an average price of $37.32, for a total transaction of $151,257.96. Following the completion of the transaction, the chief financial officer now directly owns 27,295 shares of the company’s stock, valued at approximately $1,018,649.40. The disclosure for this sale can be found here. Insiders sold 6,053 shares of company stock worth $221,498 in the last three months. Corporate insiders own 1.55% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. ARK Investment Management LLC boosted its holdings in shares of Teladoc Health by 2.9% during the 1st quarter. ARK Investment Management LLC now owns 19,466,931 shares of the health services provider’s stock valued at $1,404,150,000 after purchasing an additional 544,733 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Teladoc Health by 0.7% during the 1st quarter. Vanguard Group Inc. now owns 13,238,243 shares of the health services provider’s stock valued at $954,875,000 after purchasing an additional 98,181 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in shares of Teladoc Health by 17.1% during the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 9,140,808 shares of the health services provider’s stock valued at $839,309,000 after purchasing an additional 1,336,508 shares during the last quarter. Nikko Asset Management Americas Inc. boosted its holdings in shares of Teladoc Health by 18.2% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 8,755,058 shares of the health services provider’s stock valued at $809,843,000 after purchasing an additional 1,349,776 shares during the last quarter. Finally, Kinnevik AB publ bought a new position in shares of Teladoc Health during the 4th quarter valued at about $458,235,000. Institutional investors own 87.17% of the company’s stock.

About Teladoc Health

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Featured Articles

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Want More Great Investing Ideas?

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.